Meet The Speakers

Yoseph Barash

Principal Investigator

University of Pennsylvania, USA

Oxana Beskrovnaya

Chief Innovation Officer

Dyne Therapeutics, USA

Emanuele Buratti

Group Leader, Molecular Pathology Lab

ICGEB, Italy

Carlos Caldas

Honorary Consultant in Medical Oncology

University of Cambridge, UK, Lautenberg Center, Faculty of Medicine, The Hebrew University of Jerusalem, Israel

Massimiliano Clamer

CEO

Immagina Biotechnology srl, Italy

Christine Duthoit

CEO - CSO

RNAlead, France

David Elliott

Principal Investigator

Newcastle University, UK

Claudia Ghigna

Scientist

Institute of Molecular Genetics, Italy

Tamar Grossman

CEO

La Jolla Labs, USA

Yael Gruenbaum Cohen

Partner & Head

aMoon Alpha, Israel

Ernesto Guccione

Principal Investigator, The Guccione Lab

Icahn School of Medicine at Mount Sinai, USA

Rotem Karni

Principal Investigator

Hebrew University-Hadassah Medical School, Jerusalem, Israel, and University of Pennsylvania, USA

Michael Khan

CEO

Argonaute RNA, UK

Marcin Kortylewski

Principal Investigator

The Kortylewski Lab, City of Hope, USA

Adrian R. Krainer

St. Giles Foundation Professor

Cold Spring Harbor Laboratory, New York, USA

Anna Krichevsky

Professor of Neurology

Brigham and Women's Hospital, and Harvard Medical School, USA

Eleonora Leucci

Principal Investigator - RNA Cancer Biology Lab

KU Leuven, Belgium

Michal Lotem

Head of The Hadassah Cancer Research Institute (HCRI)

Hadassah Hebrew University Medical Center, Jerusalem, Israel

François-Thomas Michaud

CEO

Feldan Therapeutics, Canada

Min Wen Ku

Application Scientist

VectorBuilder, UK

Amir Mor

CSO

RNAble, Israel

Riccardo Panella

Chief Scientific Officer

Resalis Therapeutics, Italy

Aron Popovtzer

Director of the Sharett Institute of Oncology

Hadassah Medical Center, Israel

Ruben Postel

CSO & Scientific Founder

Sapreme Technologies, The Netherlands

Christopher Ricupero

Assistant Professor

Columbia University Irving Medical Center, USA

Caroline Robert

Head of Dermatology

Gustave Roussy Institute, France

Shai Rosenberg

Head of the Computational Medicine Service

Hadassah Hebrew University Medical Center, Jerusalem, Israel

Annie Sabbah

CTO & Co-Founder

Barcode Nanotech, Israel

Ronit Satchi-Fainaro

Director, Cancer Biology Research Center, and Director, TAU Kahn 3D BioPrinting Initiative

TAU, Israel

Claudio Sette

Principal Investigator

Catholic University of the Sacred Heart, School of Medicine, Italy

Brage Storstein Andresen

Head of Research, RNA Splicing and Disease Lab

University of Southern Denmark

Andrei Thomas-Tikhonenko

Director of Experimental Pathology

Children's Hospital of Philadelphia, USA

Igor Ulitsky

Principal Investigator, Ulitsky Lab

Weizmann Institute of Science, Israel

Talia Waxenbaum

Business & Sales Leader

1E Pharma Solutions, Israel

Peter D. Weinstein

CEO/General Counsel

Emervax, Inc., USA

Ron Weiss

Principal Investigator, The Weiss Lab

Massachusetts Institute of Technology, Boston, USA

Omer Ziv

Executive Director of RNA Biology

Eleven Therapeutics, UK